Internet use among docs increases

Share this article:
The number of physicians interacting with drug and device companies online has grown 23% since 2004 to comprise 87% of all US physicians, according to Manhattan Research. 
The research firm's ePharma Physician study found that physicians would like to use more online conferences and professional online videos for pharmaceutical, biotech and medical device product information. Physicians also show significant interest in reading medical journals online.

The study found many companies trying to integrate their sales force, marketing, and customer service functions to create a more seamless customer experience for physicians. For some practitioners, physician service portals can act as the hub of a physician's relationship with a brand. Leading portals include Shire Connect,, MerckServices and Pfizer for Professionals.       

Physician expectations of online customer service continues to increase, the study found, and as a result, companies are including relevant and useful content and tools on these portals, including: product information, links to patient education, electronic sampling, and online customer service reps. Formulary information, in particular, is a feature that physicians increasingly want to see from manufacturers, according to the study.

Physicians also visit the product websites themselves when researching treatment information. Shire's ADHD treatment Vyvanse boasts the most popular product site among pediatricians, and Merck's Januvia took the top spot among primary care physicians, according to the study.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...